首页 > 最新文献

British Journal of Ophthalmology最新文献

英文 中文
Lacrimal sac massage for congenital nasolacrimal duct obstruction: a multicentre randomised controlled trial. 泪囊按摩治疗先天性鼻泪管阻塞:多中心随机对照试验。
IF 3.7 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-08-22 DOI: 10.1136/bjo-2023-324595
Mizuki Asano, Masaki Takeuchi, Tomoko Ohno, Jutaro Nakamura, Nobuhisa Mizuki, Nozomi Matsumura

Aim: Congenital nasolacrimal duct obstruction (CNLDO) is the most common cause of epiphora and mucous discharge in the newborn. We conducted a multicentre randomised controlled trial to determine whether Crigler massage promotes the resolution of CNLDO in infants under 1 year of age.

Methods: A total of 102 infants aged 3-11 months with unilateral CNLDO were enrolled in the study. Patients were randomly assigned to the massage and non-massage groups (n=51/group). As an allocation adjustment factor, the patients were divided into age groups of 3-5, 6-8 and 9-11 months. In the massage group, the guardian performed 10 strokes two times per day for each day until resolution or 1 month. The primary endpoint was a comparison of the 1-month resolution rate in the massage and non-massage groups.

Results: This study included 49 male and 53 female patients with a mean age of 6.4±2.4 months. Overall, in this study, the resolution rate was not significantly different between the massage and non-massage groups (31.4% and 33.3%, respectively). However, the resolution rate was higher in the massage group in the 3-5 months age group among the protocol-compliant patients after excluding those with insufficient massage frequency (the massage group, 68.8% and the non-massage group, 28.6%, p=0.022).

Conclusions: There was no increase in the resolution rate after 1 month of lacrimal sac massage in patients 3-11 months old with unilateral CNLDO. However, in protocol-compliant younger age groups, Crigler massage may be effective.

Trial registration number: UMIN Clinical Trial Registry (UMIN000032840; www.umin.ac.jp/).

目的:先天性鼻泪管阻塞(CNLDO)是导致新生儿口吐白沫和粘液分泌的最常见原因。我们进行了一项多中心随机对照试验,以确定克利格勒按摩是否能促进 1 岁以下婴儿的先天性鼻泪管阻塞缓解:共有 102 名 3-11 个月大的单侧 CNLDO 婴儿参加了研究。患者被随机分配到按摩组和非按摩组(n=51/组)。作为分配调整因素,患者被分为 3-5 个月、6-8 个月和 9-11 个月三个年龄组。在按摩组中,监护人每天按摩两次,每次10下,直到病情缓解或1个月。主要终点是比较按摩组和非按摩组的 1 个月缓解率:本研究包括 49 名男性患者和 53 名女性患者,平均年龄为(6.4±2.4)个月。总体而言,按摩组和非按摩组的症状缓解率没有明显差异(分别为 31.4% 和 33.3%)。然而,在排除按摩频率不足的患者后,符合治疗方案的 3-5 个月年龄组患者中,按摩组的缓解率更高(按摩组为 68.8%,非按摩组为 28.6%,P=0.022):结论:3-11 个月大的单侧 CNLDO 患者在接受 1 个月的泪囊按摩后,症状缓解率没有增加。然而,在符合方案的较小年龄组中,克里格勒按摩可能有效:UMIN 临床试验注册表 (UMIN000032840; www.umin.ac.jp/)。
{"title":"Lacrimal sac massage for congenital nasolacrimal duct obstruction: a multicentre randomised controlled trial.","authors":"Mizuki Asano, Masaki Takeuchi, Tomoko Ohno, Jutaro Nakamura, Nobuhisa Mizuki, Nozomi Matsumura","doi":"10.1136/bjo-2023-324595","DOIUrl":"10.1136/bjo-2023-324595","url":null,"abstract":"<p><strong>Aim: </strong>Congenital nasolacrimal duct obstruction (CNLDO) is the most common cause of epiphora and mucous discharge in the newborn. We conducted a multicentre randomised controlled trial to determine whether Crigler massage promotes the resolution of CNLDO in infants under 1 year of age.</p><p><strong>Methods: </strong>A total of 102 infants aged 3-11 months with unilateral CNLDO were enrolled in the study. Patients were randomly assigned to the massage and non-massage groups (n=51/group). As an allocation adjustment factor, the patients were divided into age groups of 3-5, 6-8 and 9-11 months. In the massage group, the guardian performed 10 strokes two times per day for each day until resolution or 1 month. The primary endpoint was a comparison of the 1-month resolution rate in the massage and non-massage groups.</p><p><strong>Results: </strong>This study included 49 male and 53 female patients with a mean age of 6.4±2.4 months. Overall, in this study, the resolution rate was not significantly different between the massage and non-massage groups (31.4% and 33.3%, respectively). However, the resolution rate was higher in the massage group in the 3-5 months age group among the protocol-compliant patients after excluding those with insufficient massage frequency (the massage group, 68.8% and the non-massage group, 28.6%, p=0.022).</p><p><strong>Conclusions: </strong>There was no increase in the resolution rate after 1 month of lacrimal sac massage in patients 3-11 months old with unilateral CNLDO. However, in protocol-compliant younger age groups, Crigler massage may be effective.</p><p><strong>Trial registration number: </strong>UMIN Clinical Trial Registry (UMIN000032840; www.umin.ac.jp/).</p>","PeriodicalId":9313,"journal":{"name":"British Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139501832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictors of 24-month onset of macular fibrosis in type 3 macular neovascularisation. 3 型黄斑新生血管在 24 个月后出现黄斑纤维化的预测因素。
IF 3.7 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-08-22 DOI: 10.1136/bjo-2023-324713
Paolo Forte, Vincenzo Fontana, Julia Muzio, Luca Di Cello, Paolo Corazza, Raffaella Rosa, Donatella Musetti, Aldo Vagge, Carlo Enrico Traverso, Massimo Nicolò

Aims: To explore prognostic multimarker models for progression to macular fibrosis (MF) over 24 months specific to type 3 macular neovascularisation (T3 MNV).

Methods: This retrospective, exploratory, single-centre, cohort study comprised 65 eyes of 43 Caucasian patients with treatment naive T3 MNV, all with a 24-month follow-up post anti-VEGF therapy using a strict pro-re-nata (PRN) regimen. Data on demographic features, clinical findings, frequency of intravitreal treatments and optical coherence tomography biomarkers were collected at baseline and after 12 and 24 months of follow-up. Logistic regression models (LRM) and receiver-operating curve (C-index) analyses were performed to evaluate the prognostic ability of the studied biomarkers in discriminating between MF affected and unaffected patients.

Results: At final follow-up, MF was present in 46.2% of eyes. Subretinal hyper-reflective material (SHRM) and subretinal pigment epithelium multilaminar hyper-reflectivity (multilaminae) emerged as significant predictors for MF, with adjusted odds ratios (OR) of 18.0 (95% CL 13.4 to 24.1) and 11.8 (95% CL 8.66 to 16.0), respectively. Additionally, the presence of multifocal lesions (OR 0.04, 95% CL 0.01 to 0.30) appeared to decrease the likelihood of MF. C-indexes for the selected LRMs ranged between 0.92 and 0.88, indicating a comparably high discriminant ability. Despite consistent treatment schedules between the two groups (MF: median intravitreal treatment (IVT) number=10.5, IQR=7; non-MF: median IVT=10, IQR=6), a decline in best-corrected visual acuity was noted in the group with MF onset over the 24-month follow-up (-13.0 ETDRS letters; 95% CL -22.1 to -3.9; p=0.006).

Conclusion: Our study identifies SHRM and multilaminae as relevant predictors of 24-month onset of MF in patients with T3 MNV. These findings enrich our understanding of the development of MF in T3 MNV and can guide improved risk prognostication. Future research should consider larger samples and prospective designs to validate these predictors.

目的:探讨3型黄斑新生血管(T3 MNV)在24个月内发展为黄斑纤维化(MF)的预后多标志物模型:这项回顾性、探索性、单中心队列研究包括43名白种人T3型黄斑新生血管患者的65只眼睛,这些患者均在接受抗血管内皮生长因子治疗后24个月内采用严格的PRN治疗方案。在基线以及随访 12 个月和 24 个月后,收集了有关人口统计学特征、临床表现、玻璃体内治疗频率和光学相干断层扫描生物标志物的数据。通过逻辑回归模型(LRM)和受体运行曲线(C-index)分析,评估所研究的生物标志物在区分MF患者和未受影响患者方面的预后能力:在最终随访中,46.2%的眼球存在MF。视网膜下高反射物质(SHRM)和视网膜下色素上皮多层高反射(multilaminae)是MF的重要预测指标,调整后的几率比(OR)分别为18.0(95% CL 13.4-24.1)和11.8(95% CL 8.66-16.0)。此外,存在多灶性病变(OR 0.04,95% CL 0.01 至 0.30)似乎会降低 MF 的可能性。所选 LRM 的 C 指数介于 0.92 和 0.88 之间,表明具有相当高的判别能力。尽管两组患者的治疗方案一致(MF:玻璃体内治疗(IVT)中位数=10.5,IQR=7;非MF:IVT中位数=10,IQR=6),但在24个月的随访中,发现MF发病组的最佳矫正视力有所下降(-13.0 ETDRS字母;95% CL -22.1至-3.9;P=0.006):我们的研究发现,SHRM和多层膜是T3 MNV患者24个月后发生MF的相关预测因素。这些发现丰富了我们对 T3 MNV 中 MF 发展的认识,并可指导改善风险预后。未来的研究应考虑采用更大的样本和前瞻性设计来验证这些预测因子。
{"title":"Predictors of 24-month onset of macular fibrosis in type 3 macular neovascularisation.","authors":"Paolo Forte, Vincenzo Fontana, Julia Muzio, Luca Di Cello, Paolo Corazza, Raffaella Rosa, Donatella Musetti, Aldo Vagge, Carlo Enrico Traverso, Massimo Nicolò","doi":"10.1136/bjo-2023-324713","DOIUrl":"10.1136/bjo-2023-324713","url":null,"abstract":"<p><strong>Aims: </strong>To explore prognostic multimarker models for progression to macular fibrosis (MF) over 24 months specific to type 3 macular neovascularisation (T3 MNV).</p><p><strong>Methods: </strong>This retrospective, exploratory, single-centre, cohort study comprised 65 eyes of 43 Caucasian patients with treatment naive T3 MNV, all with a 24-month follow-up post anti-VEGF therapy using a strict pro-re-nata (PRN) regimen. Data on demographic features, clinical findings, frequency of intravitreal treatments and optical coherence tomography biomarkers were collected at baseline and after 12 and 24 months of follow-up. Logistic regression models (LRM) and receiver-operating curve (C-index) analyses were performed to evaluate the prognostic ability of the studied biomarkers in discriminating between MF affected and unaffected patients.</p><p><strong>Results: </strong>At final follow-up, MF was present in 46.2% of eyes. Subretinal hyper-reflective material (SHRM) and subretinal pigment epithelium multilaminar hyper-reflectivity (multilaminae) emerged as significant predictors for MF, with adjusted odds ratios (OR) of 18.0 (95% CL 13.4 to 24.1) and 11.8 (95% CL 8.66 to 16.0), respectively. Additionally, the presence of multifocal lesions (OR 0.04, 95% CL 0.01 to 0.30) appeared to decrease the likelihood of MF. C-indexes for the selected LRMs ranged between 0.92 and 0.88, indicating a comparably high discriminant ability. Despite consistent treatment schedules between the two groups (MF: median intravitreal treatment (IVT) number=10.5, IQR=7; non-MF: median IVT=10, IQR=6), a decline in best-corrected visual acuity was noted in the group with MF onset over the 24-month follow-up (-13.0 ETDRS letters; 95% CL -22.1 to -3.9; p=0.006).</p><p><strong>Conclusion: </strong>Our study identifies SHRM and multilaminae as relevant predictors of 24-month onset of MF in patients with T3 MNV. These findings enrich our understanding of the development of MF in T3 MNV and can guide improved risk prognostication. Future research should consider larger samples and prospective designs to validate these predictors.</p>","PeriodicalId":9313,"journal":{"name":"British Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139641611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Automated identification of fleck lesions in Stargardt disease using deep learning enhances lesion detection sensitivity and enables morphometric analysis of flecks. 利用深度学习自动识别斯塔加特病的斑点病变,提高了病变检测灵敏度,并实现了斑点的形态计量分析。
IF 3.7 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-08-22 DOI: 10.1136/bjo-2023-323592
Jasdeep Sabharwal, Tin Yan Alvin Liu, Bani Antonio-Aguirre, Mya Abousy, Tapan Patel, Cindy X Cai, Craig K Jones, Mandeep S Singh

Purpose: To classify fleck lesions and assess artificial intelligence (AI) in identifying flecks in Stargardt disease (STGD).

Methods: A retrospective study of 170 eyes from 85 consecutive patients with confirmed STGD. Fundus autofluorescence images were extracted, and flecks were manually outlined. A deep learning model was trained, and a hold-out testing subset was used to compare with manually identified flecks and for graders to assess. Flecks were clustered using K-means clustering.

Results: Of the 85 subjects, 45 were female, and the median age was 37 years (IQR 25-59). A subset of subjects (n=41) had clearly identifiable fleck lesions, and an AI was successfully trained to identify these lesions (average Dice score of 0.53, n=18). The AI segmentation had smaller (0.018 compared with 0.034 mm2, p<0.001) but more numerous flecks (75.5 per retina compared with 40.0, p<0.001), but the total size of flecks was not different. The AI model had higher sensitivity to detect flecks but resulted in more false positives. There were two clusters of flecks based on morphology: broadly, one cluster of small round flecks and another of large amorphous flecks. The per cent frequency of small round flecks negatively correlated with subject age (r=-0.31, p<0.005).

Conclusions: AI-based detection of flecks shows greater sensitivity than human graders but with a higher false-positive rate. With further optimisation to address current shortcomings, this approach could be used to prescreen subjects for clinical research. The feasibility and utility of quantifying fleck morphology in conjunction with AI-based segmentation as a biomarker of progression require further study.

目的:对Stargardt病(STGD)中的飞蚊症病变进行分类,并评估人工智能(AI)识别飞蚊症的能力:方法:对 85 名确诊 STGD 患者的 170 只眼睛进行回顾性研究。提取眼底自动荧光图像,人工勾画斑点。对深度学习模型进行了训练,并使用一个保留测试子集与人工识别的斑点进行比较,供分级人员进行评估。使用 K-means 聚类对斑点进行聚类:85 名受试者中有 45 名女性,年龄中位数为 37 岁(IQR 25-59)。一部分受试者(41 人)有可明确识别的斑点病变,人工智能经过训练后可成功识别这些病变(平均 Dice 得分为 0.53,18 人)。人工智能分割的面积更小(0.018 与 0.034 平方毫米相比,p 结论:基于人工智能的斑点检测灵敏度高于人工分级,但假阳性率较高。通过进一步优化以解决目前的不足,这种方法可用于临床研究的受试者预筛。将斑点形态量化与人工智能分级相结合作为疾病进展的生物标志物的可行性和实用性还需要进一步研究。
{"title":"Automated identification of fleck lesions in Stargardt disease using deep learning enhances lesion detection sensitivity and enables morphometric analysis of flecks.","authors":"Jasdeep Sabharwal, Tin Yan Alvin Liu, Bani Antonio-Aguirre, Mya Abousy, Tapan Patel, Cindy X Cai, Craig K Jones, Mandeep S Singh","doi":"10.1136/bjo-2023-323592","DOIUrl":"10.1136/bjo-2023-323592","url":null,"abstract":"<p><strong>Purpose: </strong>To classify fleck lesions and assess artificial intelligence (AI) in identifying flecks in Stargardt disease (STGD).</p><p><strong>Methods: </strong>A retrospective study of 170 eyes from 85 consecutive patients with confirmed STGD. Fundus autofluorescence images were extracted, and flecks were manually outlined. A deep learning model was trained, and a hold-out testing subset was used to compare with manually identified flecks and for graders to assess. Flecks were clustered using K-means clustering.</p><p><strong>Results: </strong>Of the 85 subjects, 45 were female, and the median age was 37 years (IQR 25-59). A subset of subjects (n=41) had clearly identifiable fleck lesions, and an AI was successfully trained to identify these lesions (average Dice score of 0.53, n=18). The AI segmentation had smaller (0.018 compared with 0.034 mm<sup>2</sup>, p<0.001) but more numerous flecks (75.5 per retina compared with 40.0, p<0.001), but the total size of flecks was not different. The AI model had higher sensitivity to detect flecks but resulted in more false positives. There were two clusters of flecks based on morphology: broadly, one cluster of small round flecks and another of large amorphous flecks. The per cent frequency of small round flecks negatively correlated with subject age (r=-0.31, p<0.005).</p><p><strong>Conclusions: </strong>AI-based detection of flecks shows greater sensitivity than human graders but with a higher false-positive rate. With further optimisation to address current shortcomings, this approach could be used to prescreen subjects for clinical research. The feasibility and utility of quantifying fleck morphology in conjunction with AI-based segmentation as a biomarker of progression require further study.</p>","PeriodicalId":9313,"journal":{"name":"British Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139971001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between corneal hysteresis and glaucoma in a Japanese population: the Hisayama Study. 日本人角膜滞后与青光眼之间的关系:久山研究。
IF 3.7 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-08-22 DOI: 10.1136/bjo-2023-323987
Kohta Fujiwara, Emi Ueda, Jun Hata, Satoko Nakano, Sawako Hashimoto, Shun Nakamura, Yusuke Murakami, Toshiaki Kubota, Takeshi Yoshitomi, Toshiharu Ninomiya, Koh-Hei Sonoda

Aims: To investigate the association between corneal hysteresis and the presence of glaucoma and its subtypes in a general Japanese population.

Methods: We analysed the data of 2338 Japanese community-dwellers aged ≥40 years (1059 men, 1279 women) who underwent an eye examination in 2018 as part of the population-based, cross-sectional Hisayama Study. Participants were divided into quartile levels of corneal hysteresis, which had been measured with an ocular response analyzer. Glaucoma was defined based on the International Society of Geographical and Epidemiological Ophthalmology criteria. We conducted a logistic regression analysis to determine the ORs and their 95% CIs for the presence of outcomes according to the corneal hysteresis quartiles.

Results: Glaucoma was diagnosed in 154 participants: primary open-angle glaucoma (POAG), n=115; primary angle-closure glaucoma, n=17; exfoliation glaucoma, n=21 and secondary glaucoma without exfoliation glaucoma, n=1. After adjustment for confounders, the OR for prevalent glaucoma was significantly increased in the participants in the first corneal-hysteresis quartile compared with those in the fourth quartile (OR: 1.80; 95% CI: 1.03 to 3.17). Regarding glaucoma subtypes, the first-quartile participants had significantly greater likelihoods of the presence of POAG (OR: 1.63; 95% CI: 1.02 to 2.61) and exfoliation glaucoma (OR: 6.49; 95% CI: 1.44 to 29.30) compared with those in the third and fourth quartiles after adjustment for potential confounders.

Conclusions: These results demonstrated a significant inverse association between corneal hysteresis and the likelihood of glaucoma, suggesting that the measurement of corneal hysteresis would provide useful information for elucidating the aetiology of glaucoma.

目的:研究日本普通人群中角膜滞后与青光眼及其亚型之间的关联:我们分析了2338名年龄≥40岁的日本社区居民(男性1059人,女性1279人)的数据,他们在2018年接受了眼科检查,这是基于人群的横断面久山研究的一部分。参试者的角膜滞后被分为四分位水平,角膜滞后是通过眼部反应分析仪测量的。青光眼的定义基于国际地理与流行病学眼科学会的标准。我们进行了逻辑回归分析,以确定根据角膜滞后四分位数得出的结果的ORs及其95% CI:154名参与者被诊断为青光眼:原发性开角型青光眼(POAG),115人;原发性闭角型青光眼,17人;剥脱性青光眼,21人;继发性青光眼(无剥脱性青光眼),1人。在对混杂因素进行调整后,角膜滞后第一四分位数的参与者与第四四分位数的参与者相比,青光眼发病率明显增加(OR:1.80;95% CI:1.03 至 3.17)。在青光眼亚型方面,经调整潜在的混杂因素后,第一四分位数参与者患 POAG(OR:1.63;95% CI:1.02 至 2.61)和剥脱性青光眼(OR:6.49;95% CI:1.44 至 29.30)的可能性明显高于第三和第四四分位数参与者:这些结果表明,角膜滞后与患青光眼的可能性之间存在明显的反比关系,这表明测量角膜滞后可为阐明青光眼的病因提供有用的信息。
{"title":"Association between corneal hysteresis and glaucoma in a Japanese population: the Hisayama Study.","authors":"Kohta Fujiwara, Emi Ueda, Jun Hata, Satoko Nakano, Sawako Hashimoto, Shun Nakamura, Yusuke Murakami, Toshiaki Kubota, Takeshi Yoshitomi, Toshiharu Ninomiya, Koh-Hei Sonoda","doi":"10.1136/bjo-2023-323987","DOIUrl":"10.1136/bjo-2023-323987","url":null,"abstract":"<p><strong>Aims: </strong>To investigate the association between corneal hysteresis and the presence of glaucoma and its subtypes in a general Japanese population.</p><p><strong>Methods: </strong>We analysed the data of 2338 Japanese community-dwellers aged ≥40 years (1059 men, 1279 women) who underwent an eye examination in 2018 as part of the population-based, cross-sectional Hisayama Study. Participants were divided into quartile levels of corneal hysteresis, which had been measured with an ocular response analyzer. Glaucoma was defined based on the International Society of Geographical and Epidemiological Ophthalmology criteria. We conducted a logistic regression analysis to determine the ORs and their 95% CIs for the presence of outcomes according to the corneal hysteresis quartiles.</p><p><strong>Results: </strong>Glaucoma was diagnosed in 154 participants: primary open-angle glaucoma (POAG), n=115; primary angle-closure glaucoma, n=17; exfoliation glaucoma, n=21 and secondary glaucoma without exfoliation glaucoma, n=1. After adjustment for confounders, the OR for prevalent glaucoma was significantly increased in the participants in the first corneal-hysteresis quartile compared with those in the fourth quartile (OR: 1.80; 95% CI: 1.03 to 3.17). Regarding glaucoma subtypes, the first-quartile participants had significantly greater likelihoods of the presence of POAG (OR: 1.63; 95% CI: 1.02 to 2.61) and exfoliation glaucoma (OR: 6.49; 95% CI: 1.44 to 29.30) compared with those in the third and fourth quartiles after adjustment for potential confounders.</p><p><strong>Conclusions: </strong>These results demonstrated a significant inverse association between corneal hysteresis and the likelihood of glaucoma, suggesting that the measurement of corneal hysteresis would provide useful information for elucidating the aetiology of glaucoma.</p>","PeriodicalId":9313,"journal":{"name":"British Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140109154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of subconjunctival TRIamcinolone acetonide injection and intravitreal dexamethasone (OZurdex) injection for uveitic and postoperative macular oedema: the TRIOZ study. 对比结膜下注射 TRIamcinolone acetonide 和玻璃体内注射地塞米松 (OZurdex) 治疗葡萄膜炎和术后黄斑水肿:TRIOZ 研究。
IF 3.7 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-08-21 DOI: 10.1136/bjo-2023-325128
Chloé Couret, Pierre-Antoine Quintart, Alexandra Poinas, Marie-Anne Vibet, Marie-Laure Le Lez, Pierre Labalette, Bahram Bodaghi, Marc Labetoulle, Marie-Bénédicte Rougier, Karine Angioi, Christophe Chiquet, Cherif Titah, Laurent Kodjikian, Stephanie Baillif, Catherine Creuzot-Garcher, Marie-Hélène Errera, Michel Weber

Aims: To compare effectiveness of subconjunctival triamcinolone acetonide injections and intravitreal injections of dexamethasone 700 µg implants in reducing central macular thickness (CMT) in uveitic and postoperative macular oedema (ME).

Methods: We conducted an open-label, French multicentre randomised comparative trial with a logarithmic CMT non-inferiority margin set at 0.06. Patients were adults with non-infectious inflammatory ME, without any contraindication to the treatments. They were randomised 1:1 to receive either triamcinolone or dexamethasone. The primary endpoint was the difference in CMT among treated eyes between baseline and 2 months, measured with spectral-domain optical coherence tomography. Secondary outcomes included visual acuity, laser flare, vitreous haze, duration of action, tolerance to injections and adverse events.

Results: Between January 2016 and January 2020, 106 patients were enrolled (54 in the triamcinolone group and 52 in the dexamethasone group). Subconjunctival triamcinolone injections seemed to be non-inferior to intravitreal dexamethasone injections, especially at month 3 (and nearly at month 1). Nevertheless, we could not demonstrate it, with a treatment effect at month 2 of 0.05 (0.01 ; 0.09) (p value=0.001). This was corroborated by post hoc analyses in the postoperative subgroup, for whom the non-inferiority was nearly demonstrated at month 2 with a treatment effect of 0.02 (-0.03 ; 0.08) (p=0.37). There was no significant difference in the occurrence of adverse effects.

Conclusion: We could not demonstrate the non-inferiority of triamcinolone injections at month 2. Nevertheless, they showed some efficacity, particularly in treating postoperative ME, being as safe as dexamethasone injections, without any loss of chance if a therapeutic switch is necessary.

目的:比较结膜下注射曲安奈德曲安奈德和玻璃体内注射地塞米松 700 µg 植入剂在减少葡萄膜炎和术后黄斑水肿(ME)患者黄斑中心厚度(CMT)方面的效果:我们进行了一项开放标签的法国多中心随机比较试验,CMT 非劣效值对数差定为 0.06。患者均为成人非感染性炎症性 ME 患者,无任何治疗禁忌症。他们按1:1的比例随机接受曲安奈德或地塞米松治疗。主要终点是通过光谱域光学相干断层扫描测量治疗眼在基线和两个月之间的CMT差异。次要结果包括视力、激光耀斑、玻璃体混浊、作用持续时间、对注射的耐受性和不良事件:2016年1月至2020年1月期间,共有106名患者入组(曲安奈德组54人,地塞米松组52人)。结膜下注射曲安奈德似乎不劣于玻璃体内注射地塞米松,尤其是在第 3 个月(几乎在第 1 个月)。然而,我们无法证明这一点,第 2 个月的治疗效果为 0.05 (0.01 ; 0.09) (p 值=0.001)。这一点在术后亚组的事后分析中得到了证实,术后亚组在第 2 个月的治疗效果为 0.02 (-0.03 ; 0.08) (p=0.37) ,几乎证明了非劣效性。不良反应发生率无明显差异:尽管如此,三苯氧胺注射液仍显示出一定的疗效,尤其是在治疗术后 ME 方面,其安全性与地塞米松注射液不相上下,如果需要转换疗法,也不会失去任何机会。
{"title":"Comparison of subconjunctival TRIamcinolone acetonide injection and intravitreal dexamethasone (OZurdex) injection for uveitic and postoperative macular oedema: the TRIOZ study.","authors":"Chloé Couret, Pierre-Antoine Quintart, Alexandra Poinas, Marie-Anne Vibet, Marie-Laure Le Lez, Pierre Labalette, Bahram Bodaghi, Marc Labetoulle, Marie-Bénédicte Rougier, Karine Angioi, Christophe Chiquet, Cherif Titah, Laurent Kodjikian, Stephanie Baillif, Catherine Creuzot-Garcher, Marie-Hélène Errera, Michel Weber","doi":"10.1136/bjo-2023-325128","DOIUrl":"https://doi.org/10.1136/bjo-2023-325128","url":null,"abstract":"<p><strong>Aims: </strong>To compare effectiveness of subconjunctival triamcinolone acetonide injections and intravitreal injections of dexamethasone 700 µg implants in reducing central macular thickness (CMT) in uveitic and postoperative macular oedema (ME).</p><p><strong>Methods: </strong>We conducted an open-label, French multicentre randomised comparative trial with a logarithmic CMT non-inferiority margin set at 0.06. Patients were adults with non-infectious inflammatory ME, without any contraindication to the treatments. They were randomised 1:1 to receive either triamcinolone or dexamethasone. The primary endpoint was the difference in CMT among treated eyes between baseline and 2 months, measured with spectral-domain optical coherence tomography. Secondary outcomes included visual acuity, laser flare, vitreous haze, duration of action, tolerance to injections and adverse events.</p><p><strong>Results: </strong>Between January 2016 and January 2020, 106 patients were enrolled (54 in the triamcinolone group and 52 in the dexamethasone group). Subconjunctival triamcinolone injections seemed to be non-inferior to intravitreal dexamethasone injections, especially at month 3 (and nearly at month 1). Nevertheless, we could not demonstrate it, with a treatment effect at month 2 of 0.05 (0.01 ; 0.09) (p value=0.001). This was corroborated by post hoc analyses in the postoperative subgroup, for whom the non-inferiority was nearly demonstrated at month 2 with a treatment effect of 0.02 (-0.03 ; 0.08) (p=0.37). There was no significant difference in the occurrence of adverse effects.</p><p><strong>Conclusion: </strong>We could not demonstrate the non-inferiority of triamcinolone injections at month 2. Nevertheless, they showed some efficacity, particularly in treating postoperative ME, being as safe as dexamethasone injections, without any loss of chance if a therapeutic switch is necessary.</p>","PeriodicalId":9313,"journal":{"name":"British Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142016456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reattachment rate with pneumatic retinopexy versus pars plana vitrectomy for single break rhegmatogenous retinal detachment. 气压式视网膜剥离术与玻璃体旁切除术治疗单个破损流变性视网膜脱离的再粘连率。
IF 3.7 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-08-19 DOI: 10.1136/bjo-2023-324005
Aurora Pecaku, Isabela Martins Melo, Reut Shor, Carolina L M Francisconi, Samara Barbara Marafon, Varun Chaudhary, Roxane Jo Hillier, Rajeev H Muni

Aim: To assess the primary reattachment rate (PARR) in pneumatic retinopexy (PnR) versus pars plana vitrectomy (PPV) for rhegmatogenous retinal detachment (RRD) meeting the Pneumatic Retinopexy versus Vitrectomy for the Management of Primary Rhegmatogenous Retinal Detachment Outcomes Randomised Trial (PIVOT) criteria with a single break in detached retina.

Methods: A post hoc analysis of two clinical trials. To be included, patients with primary RRD had to meet PIVOT criteria but could have only one break in the detached retina. Patients with additional pathology in the attached retina were included in a secondary analysis. The primary outcome was PARR following PnR versus PPV at 1-year postoperatively.

Results: 162 patients were included. 53% (86/162) underwent PnR and 47% (76/162) had a PPV. 99% (85/86) and 86.8% (66/76) completed the 1-year follow-up visits in the PnR and PPV groups, respectively. PARR was 88.2% (75/85) in the PnR group and 90.9% (60/66) in the PPV group (p=0.6) with a mean postoperative logMAR best-corrected visual acuity of 0.19±0.25 versus 0.34±0.37 (Snellen 20/30 vs 20/44) (p=0.01) each in the PnR and PPV groups, respectively.In an additional analysis of patients who were also allowed to have any pathology in the attached retina, the PARR was 85% (91/107) and 91.6% (66/72) in the PnR and PPV groups, respectively (p=0.18).

Conclusions: PnR and PPV provide similar long-term PARR in a substantial proportion of patients meeting PIVOT criteria with only a single break in the detached retina. Therefore, in patients meeting these specific criteria, PnR is an appropriate first-line therapy as it offers superior functional outcomes without compromising PARR.

目的:评估符合 "气动视网膜剥离术与玻璃体切除术治疗原发性风湿性视网膜脱落结果随机试验"(PIVOT)标准的风湿性视网膜脱落(RRD)患者中,脱落视网膜单一断裂的原发性再附着率(PARR):方法:对两项临床试验进行事后分析。原发性RRD患者必须符合PIVOT标准,但脱落视网膜只能有一处破损,方可纳入试验。附着视网膜有其他病变的患者被纳入二次分析。主要结果是术后1年PnR与PPV的PARR:结果:共纳入 162 例患者。53%(86/162)的患者接受了 PnR,47%(76/162)的患者接受了 PPV。PnR组和PPV组分别有99%(85/86)和86.8%(66/76)的患者完成了为期1年的随访。PnR 组的 PARR 为 88.2%(75/85),PPV 组的 PARR 为 90.9%(60/66)(P=0.6),PnR 组和 PPV 组的术后平均 logMAR 最佳矫正视力分别为 0.19±0.25 对 0.34±0.37(斯奈伦 20/30 对 20/44)(P=0.01)。在对附着视网膜有任何病变的患者进行的额外分析中,PnR 组和 PPV 组的 PARR 分别为 85%(91/107)和 91.6%(66/72)(P=0.18):PnR和PPV可为相当一部分符合PIVOT标准且脱落视网膜仅有一处断裂的患者提供相似的长期PARR。因此,对于符合这些特定标准的患者,PnR 是一种合适的一线治疗方法,因为它能在不影响 PARR 的情况下提供更好的功能性结果。
{"title":"Reattachment rate with pneumatic retinopexy versus pars plana vitrectomy for single break rhegmatogenous retinal detachment.","authors":"Aurora Pecaku, Isabela Martins Melo, Reut Shor, Carolina L M Francisconi, Samara Barbara Marafon, Varun Chaudhary, Roxane Jo Hillier, Rajeev H Muni","doi":"10.1136/bjo-2023-324005","DOIUrl":"https://doi.org/10.1136/bjo-2023-324005","url":null,"abstract":"<p><strong>Aim: </strong>To assess the primary reattachment rate (PARR) in pneumatic retinopexy (PnR) versus pars plana vitrectomy (PPV) for rhegmatogenous retinal detachment (RRD) meeting the Pneumatic Retinopexy versus Vitrectomy for the Management of Primary Rhegmatogenous Retinal Detachment Outcomes Randomised Trial (PIVOT) criteria with a single break in detached retina.</p><p><strong>Methods: </strong>A post hoc analysis of two clinical trials. To be included, patients with primary RRD had to meet PIVOT criteria but could have only one break in the detached retina. Patients with additional pathology in the attached retina were included in a secondary analysis. The primary outcome was PARR following PnR versus PPV at 1-year postoperatively.</p><p><strong>Results: </strong>162 patients were included. 53% (86/162) underwent PnR and 47% (76/162) had a PPV. 99% (85/86) and 86.8% (66/76) completed the 1-year follow-up visits in the PnR and PPV groups, respectively. PARR was 88.2% (75/85) in the PnR group and 90.9% (60/66) in the PPV group (p=0.6) with a mean postoperative logMAR best-corrected visual acuity of 0.19±0.25 versus 0.34±0.37 (Snellen 20/30 vs 20/44) (p=0.01) each in the PnR and PPV groups, respectively.In an additional analysis of patients who were also allowed to have any pathology in the attached retina, the PARR was 85% (91/107) and 91.6% (66/72) in the PnR and PPV groups, respectively (p=0.18).</p><p><strong>Conclusions: </strong>PnR and PPV provide similar long-term PARR in a substantial proportion of patients meeting PIVOT criteria with only a single break in the detached retina. Therefore, in patients meeting these specific criteria, PnR is an appropriate first-line therapy as it offers superior functional outcomes without compromising PARR.</p>","PeriodicalId":9313,"journal":{"name":"British Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142003680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predicting visual outcomes in keratoprosthesis surgery with critical flicker fusion frequency, B-scan, visual electrophysiology and endoscopy. 利用临界闪烁融合频率、B-扫描、视觉电生理学和内窥镜检查预测角膜移植手术的视觉效果。
IF 3.7 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-08-17 DOI: 10.1136/bjo-2024-325719
Guangcan Xu, Haolan Qi, Qianwei He, Mingxiong Chen, Junxia Fu, Qun Wang, Biyue Chen, Qing Hua Yang, Yifei Huang, Shihui Wei, Liqiang Wang

Purpose: This study evaluates the predictive power of the critical flicker fusion frequency (CFF) test for visual outcomes in keratoprosthesis (KPro) candidates, comparing its accuracy with B-scan ultrasound, flash visual evoked potentials (fVEP) and endoscopy.

Methods: The study included 42 patients (42 eyes) scheduled for KPro surgery with a median follow-up period of 6 months. The receiver operating characteristic curve identified the cut-off threshold for CFF in the model development study (17 eyes). All patients in the comparison study (25 eyes) underwent preoperative assessments including trichromatic CFF (red, green and yellow), B-scan ultrasound, fVEP and perioperative endoscopy. Results were classified as either favourable or unfavourable predictors of visual outcomes based on predefined criteria. Sensitivity and specificity of each assessment were calculated based on postoperative best-corrected visual acuity (BCVA)≥20/200. The Bland-Altman test assessed the consistency between CFF-predicted BCVA and actual BCVA.

Results: Among the trichromatic CFF tests, the yellow-CFF (yCFF) exhibited the highest area under the curve value of 0.97 and a cut-off threshold at 10 Hz for predicting postoperative BCVA≥20/200 (p<0.05). yCFF achieved 90% sensitivity and 80% specificity in predicting satisfactory postoperative outcomes. Endoscopy had 80% sensitivity and 80% specificity, B-scan showed 70% sensitivity and 60% specificity, and fVEP had 75% sensitivity and 40% specificity. yCFF showed a mean bias of 0.091 logarithm of the minimum angle of resolution (logMAR) in postoperative prediction.

Conclusions: The CFF test provides robust visual function evaluation in KPro candidates. It demonstrates superior predictive accuracy for visual prognosis compared with routine ophthalmologic examinations, such as B-scan ultrasonography, fVEP and endoscopy.

目的:本研究评估了临界闪烁融合频率(CFF)测试对角膜前列腺成形术(KPro)候选者视觉结果的预测能力,并将其准确性与B扫描超声波、闪光视觉诱发电位(fVEP)和内窥镜检查进行了比较:研究包括 42 名计划接受 KPro 手术的患者(42 只眼),中位随访时间为 6 个月。在模型开发研究(17 眼)中,接收器操作特征曲线确定了 CFF 的临界值。对比研究中的所有患者(25 眼)都接受了术前评估,包括三基色 CFF(红、绿、黄)、B 扫描超声波、fVEP 和围手术期内窥镜检查。根据预先确定的标准,评估结果被归类为对视觉结果有利或不利的预测因素。根据术后最佳矫正视力(BCVA)≥20/200计算每项评估的敏感性和特异性。Bland-Altman检验评估了CFF预测的BCVA与实际BCVA之间的一致性:结果:在三基色 CFF 测试中,黄色 CFF(yCFF)的曲线下面积值最高,为 0.97,预测术后 BCVA≥20/200 的临界值为 10 Hz(p 结论:CFF 测试提供了可靠的视觉功能:CFF 测试为 KPro 候选者提供了可靠的视觉功能评估。与 B-scan 超声波检查、fVEP 和内窥镜检查等常规眼科检查相比,它对视觉预后的预测准确性更高。
{"title":"Predicting visual outcomes in keratoprosthesis surgery with critical flicker fusion frequency, B-scan, visual electrophysiology and endoscopy.","authors":"Guangcan Xu, Haolan Qi, Qianwei He, Mingxiong Chen, Junxia Fu, Qun Wang, Biyue Chen, Qing Hua Yang, Yifei Huang, Shihui Wei, Liqiang Wang","doi":"10.1136/bjo-2024-325719","DOIUrl":"https://doi.org/10.1136/bjo-2024-325719","url":null,"abstract":"<p><strong>Purpose: </strong>This study evaluates the predictive power of the critical flicker fusion frequency (CFF) test for visual outcomes in keratoprosthesis (KPro) candidates, comparing its accuracy with B-scan ultrasound, flash visual evoked potentials (fVEP) and endoscopy.</p><p><strong>Methods: </strong>The study included 42 patients (42 eyes) scheduled for KPro surgery with a median follow-up period of 6 months. The receiver operating characteristic curve identified the cut-off threshold for CFF in the model development study (17 eyes). All patients in the comparison study (25 eyes) underwent preoperative assessments including trichromatic CFF (red, green and yellow), B-scan ultrasound, fVEP and perioperative endoscopy. Results were classified as either favourable or unfavourable predictors of visual outcomes based on predefined criteria. Sensitivity and specificity of each assessment were calculated based on postoperative best-corrected visual acuity (BCVA)≥20/200. The Bland-Altman test assessed the consistency between CFF-predicted BCVA and actual BCVA.</p><p><strong>Results: </strong>Among the trichromatic CFF tests, the yellow-CFF (yCFF) exhibited the highest area under the curve value of 0.97 and a cut-off threshold at 10 Hz for predicting postoperative BCVA≥20/200 (p<0.05). yCFF achieved 90% sensitivity and 80% specificity in predicting satisfactory postoperative outcomes. Endoscopy had 80% sensitivity and 80% specificity, B-scan showed 70% sensitivity and 60% specificity, and fVEP had 75% sensitivity and 40% specificity. yCFF showed a mean bias of 0.091 logarithm of the minimum angle of resolution (logMAR) in postoperative prediction.</p><p><strong>Conclusions: </strong>The CFF test provides robust visual function evaluation in KPro candidates. It demonstrates superior predictive accuracy for visual prognosis compared with routine ophthalmologic examinations, such as B-scan ultrasonography, fVEP and endoscopy.</p>","PeriodicalId":9313,"journal":{"name":"British Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141995394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of weekly dose of 1% atropine for myopia control in Chinese children 每周使用 1%阿托品控制中国儿童近视的疗效
IF 4.1 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-08-09 DOI: 10.1136/bjo-2023-324615
Linlin Du, Li Ding, Jun Chen, Jingjing Wang, Jinliuxing Yang, Sichen Liu, Xun Xu, Xiangui He, Jiannan Huang, Mengjun Zhu
Purpose To assess the effect of weekly 1% atropine use on children’s myopia progression and whether the effect is sustainable. Methods Medical records of myopic children aged 3–15 years receiving weekly 1% atropine for more than 1 year were retrospectively reviewed. Axial length (AL) and spherical equivalent refraction (SER) at every visit were collected. The changes in AL or SER over time were analysed using generalised estimating equation. The related factors of myopic progression were performed by multiple linear regression. The performance of short-term AL change to predict atropine-poor responders (AL change >0.2 mm/year) was assessed using receiver operating characteristic analysis. Results A total of 694 participants with a mean age of 8.83 years were included. The participants with follow-up time reached 1, 2, 3 and 4 years were 256 (36.9%), 250 (36.0%), 143 (20.6%) and 45 (6.5%) separately. The cumulative change in AL was 0.05 mm, 0.24 mm, 0.47 mm, 0.56 mm separately for 1-year, 2-year, 3-year and 4- year treatment. Approximate 0.20 mm elongation per year was observed since the second-year of the treatment. Older age and lower initial myopic refraction were independently associated with less myopic progression. A decrease in AL of more than 0.04 mm during the initial 2 months could serve as an indicator for identifying fast progressors (AL change >0.2 mm/year) over a 2-year period, with sensitivity and specificity rates of 0.78 and 0.73, respectively. Conclusion Weekly 1% atropine may be a potentially effective treatment with longer lasting effects for children with myopia control especially in those with older age and lower myopia. Data are available on reasonable request. The data that support the findings of this study are available from the corresponding author, MZ, on reasonable request.
目的 评估每周使用 1%阿托品对儿童近视发展的影响,以及这种影响是否具有持续性。方法 回顾性审查每周使用 1%阿托品超过 1 年的 3-15 岁近视儿童的病历。收集每次就诊时的轴长(AL)和球面等效屈光度(SER)。使用广义估计方程分析了 AL 或 SER 随时间的变化。通过多元线性回归分析近视发展的相关因素。使用接收器操作特征分析法评估了短期AL变化预测阿托品不良反应者(AL变化>0.2毫米/年)的性能。结果 共纳入 694 名参与者,平均年龄为 8.83 岁。随访时间达到 1、2、3 和 4 年的参与者分别为 256 人(36.9%)、250 人(36.0%)、143 人(20.6%)和 45 人(6.5%)。在 1 年、2 年、3 年和 4 年的治疗中,AL 的累积变化分别为 0.05 毫米、0.24 毫米、0.47 毫米和 0.56 毫米。从治疗的第二年开始,每年大约有 0.20 毫米的伸长。年龄越大、初始近视屈光度越低,近视进展越小。在最初的两个月中,AL 下降超过 0.04 毫米可作为识别两年内快速进展者(AL 变化大于 0.2 毫米/年)的指标,其敏感性和特异性分别为 0.78 和 0.73。结论 每周使用 1%阿托品可能是一种有效的治疗方法,对儿童近视控制有较持久的效果,尤其是对年龄较大和近视度数较低的儿童。如有合理要求,可提供相关数据。支持本研究结果的数据可向通讯作者 MZ 索取。
{"title":"Efficacy of weekly dose of 1% atropine for myopia control in Chinese children","authors":"Linlin Du, Li Ding, Jun Chen, Jingjing Wang, Jinliuxing Yang, Sichen Liu, Xun Xu, Xiangui He, Jiannan Huang, Mengjun Zhu","doi":"10.1136/bjo-2023-324615","DOIUrl":"https://doi.org/10.1136/bjo-2023-324615","url":null,"abstract":"Purpose To assess the effect of weekly 1% atropine use on children’s myopia progression and whether the effect is sustainable. Methods Medical records of myopic children aged 3–15 years receiving weekly 1% atropine for more than 1 year were retrospectively reviewed. Axial length (AL) and spherical equivalent refraction (SER) at every visit were collected. The changes in AL or SER over time were analysed using generalised estimating equation. The related factors of myopic progression were performed by multiple linear regression. The performance of short-term AL change to predict atropine-poor responders (AL change >0.2 mm/year) was assessed using receiver operating characteristic analysis. Results A total of 694 participants with a mean age of 8.83 years were included. The participants with follow-up time reached 1, 2, 3 and 4 years were 256 (36.9%), 250 (36.0%), 143 (20.6%) and 45 (6.5%) separately. The cumulative change in AL was 0.05 mm, 0.24 mm, 0.47 mm, 0.56 mm separately for 1-year, 2-year, 3-year and 4- year treatment. Approximate 0.20 mm elongation per year was observed since the second-year of the treatment. Older age and lower initial myopic refraction were independently associated with less myopic progression. A decrease in AL of more than 0.04 mm during the initial 2 months could serve as an indicator for identifying fast progressors (AL change >0.2 mm/year) over a 2-year period, with sensitivity and specificity rates of 0.78 and 0.73, respectively. Conclusion Weekly 1% atropine may be a potentially effective treatment with longer lasting effects for children with myopia control especially in those with older age and lower myopia. Data are available on reasonable request. The data that support the findings of this study are available from the corresponding author, MZ, on reasonable request.","PeriodicalId":9313,"journal":{"name":"British Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":4.1,"publicationDate":"2024-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141910447","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Longitudinal assessment of female carriers of choroideremia using multimodal retinal imaging 利用多模态视网膜成像对脉络膜血症女性携带者进行纵向评估
IF 4.1 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-08-09 DOI: 10.1136/bjo-2024-325578
Sena A Gocuk, Lauren N Ayton, Thomas L Edwards, Myra B McGuinness, Robert E Maclaren, Laura J Taylor, Jasleen K Jolly
Background/aims Female choroideremia carriers present with a spectrum of disease severity. Unlike in men, the rate of disease progression has not been well characterised in carriers. This longitudinal study aimed to determine the rate of retinal degeneration in choroideremia carriers, using multimodal imaging and microperimetry. Methods Choroideremia carriers previously seen at Oxford Eye Hospital (United Kingdom) between 2012 and 2017 returned for testing between 2015 and 2023, providing up to 11 years’ follow-up data. Participants had optical coherence tomography, fundus-tracked microperimetry and fundus autofluorescence (FAF) imaging performed. Results Thirty-four eyes of 17 choroideremia carriers were examined using multimodal imaging. Median age was 44 (range: 15–73) years at baseline and median follow-up duration was 7 (range: 1–11) years. At baseline, phenotype was classified as fine (n=5 eyes), coarse (n=13 eyes), geographic (n=12 eyes) or male pattern (n=4 eyes). Thirteen patients showed no change in phenotype classification, four showed slight changes associated with choroideremia-related retinal degeneration. Despite this, carriers with severe retinal phenotypes had a statistically significant decline in average retinal sensitivity (−0.7 dB and −0.8 dB per year, respectively, p<0.001), area of geographic loss defined by FAF (+2.5 mm2 and +3.7 mm2 per year, respectively, p<0.001) and thinning of the photoreceptor complex (up to −2.8 microns and −10.3 microns per year, p<0.001). Conclusion Choroideremia carriers, particularly those with severe retinal phenotypes, exhibit progressive retinal degeneration, as evident by multimodal imaging biomarkers and functional testing. Clinicians should not rely on retinal severity classification alone to assess disease progression. No data are available.
背景/目的 女性脉络膜血症携带者的病情严重程度不一。与男性不同,携带者的疾病进展速度尚未得到很好的描述。这项纵向研究旨在利用多模态成像和显微视力测定法确定脉络膜血症携带者视网膜变性的速度。方法 2012年至2017年期间曾在英国牛津眼科医院就诊的脉络膜血症携带者在2015年至2023年期间返回接受检测,提供长达11年的随访数据。参与者接受了光学相干断层扫描、眼底跟踪微透视测量和眼底自动荧光(FAF)成像。结果 使用多模态成像检查了 17 名脉络膜血症携带者的 34 只眼睛。基线年龄中位数为 44 岁(范围:15-73 岁),随访时间中位数为 7 年(范围:1-11 年)。基线时,表型分为精细型(5 眼)、粗糙型(13 眼)、地域型(12 眼)或男性型(4 眼)。13名患者的表型分类没有变化,4名患者的表型发生了与脉络膜血症相关的视网膜变性的轻微变化。尽管如此,严重视网膜表型携带者的平均视网膜灵敏度(每年分别为-0.7分贝和-0.8分贝,p<0.001)、FAF定义的地理损失面积(每年分别为+2.5平方毫米和+3.7平方毫米,p<0.001)和感光复合体变薄(每年分别为-2.8微米和-10.3微米,p<0.001)均有统计学意义的显著下降。结论脉络膜血症携带者,尤其是那些视网膜表型严重的携带者,会表现出进行性视网膜变性,这在多模态成像生物标志物和功能测试中均可明显看出。临床医生不应仅依赖视网膜严重程度分类来评估疾病进展。暂无数据。
{"title":"Longitudinal assessment of female carriers of choroideremia using multimodal retinal imaging","authors":"Sena A Gocuk, Lauren N Ayton, Thomas L Edwards, Myra B McGuinness, Robert E Maclaren, Laura J Taylor, Jasleen K Jolly","doi":"10.1136/bjo-2024-325578","DOIUrl":"https://doi.org/10.1136/bjo-2024-325578","url":null,"abstract":"Background/aims Female choroideremia carriers present with a spectrum of disease severity. Unlike in men, the rate of disease progression has not been well characterised in carriers. This longitudinal study aimed to determine the rate of retinal degeneration in choroideremia carriers, using multimodal imaging and microperimetry. Methods Choroideremia carriers previously seen at Oxford Eye Hospital (United Kingdom) between 2012 and 2017 returned for testing between 2015 and 2023, providing up to 11 years’ follow-up data. Participants had optical coherence tomography, fundus-tracked microperimetry and fundus autofluorescence (FAF) imaging performed. Results Thirty-four eyes of 17 choroideremia carriers were examined using multimodal imaging. Median age was 44 (range: 15–73) years at baseline and median follow-up duration was 7 (range: 1–11) years. At baseline, phenotype was classified as fine (n=5 eyes), coarse (n=13 eyes), geographic (n=12 eyes) or male pattern (n=4 eyes). Thirteen patients showed no change in phenotype classification, four showed slight changes associated with choroideremia-related retinal degeneration. Despite this, carriers with severe retinal phenotypes had a statistically significant decline in average retinal sensitivity (−0.7 dB and −0.8 dB per year, respectively, p<0.001), area of geographic loss defined by FAF (+2.5 mm2 and +3.7 mm2 per year, respectively, p<0.001) and thinning of the photoreceptor complex (up to −2.8 microns and −10.3 microns per year, p<0.001). Conclusion Choroideremia carriers, particularly those with severe retinal phenotypes, exhibit progressive retinal degeneration, as evident by multimodal imaging biomarkers and functional testing. Clinicians should not rely on retinal severity classification alone to assess disease progression. No data are available.","PeriodicalId":9313,"journal":{"name":"British Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":4.1,"publicationDate":"2024-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141910451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deep sequencing as a diagnostic tool in patients with suspected primary vitreoretinal lymphoma 将深度测序作为疑似原发性玻璃体视网膜淋巴瘤患者的诊断工具
IF 4.1 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-08-09 DOI: 10.1136/bjo-2023-324769
Charlene Choo, Olivia Cote, Karina Bostwick, Matthew Regueiro, Jill Wells, Hans E Grossniklaus, John Gonzales, Steven Yeh, Armin Hinterwirth, Thuy Doan, Jessica G Shantha
Purpose To compare the diagnostic utility of metagenomic deep sequencing (MDS) to cytology, flow cytometry and gene rearrangement by PCR in ocular samples of patients with suspected vitreoretinal lymphoma (VRL). Methods Patients with suspected VRL underwent ocular sampling of one or both eyes at the Emory Eye Center from September 2017 to June 2022. Ocular samples were evaluated with MDS and conventional diagnostics. MDS was performed at the Ralph and Sophie Heintz Laboratory at the F.I. Proctor Foundation. Relevant demographic and clinical data were retrospectively collected from medical records. Patients were diagnosed with VRL based on clinical assessment and conventional diagnostic testing. Results This study included 13 patients with suspected VRL who underwent diagnostic vitrectomy, including 1 patient who had an additional subretinal biopsy. Six patients (46.2%) were diagnosed with VRL. Among patients diagnosed with VRL, MDS detected pathogenic mutations in 5 out of 6 patients (83.3%) while cytology was positive for VRL in 4 out of 6 patients (66.7%), flow cytometry in 4 out of 4 patients (100.0%) and PCR in 4 out of 4 patients (100.0%). MDS detected mutations in MYD88 in 2 out of 6 patients diagnosed with VRL. In 7 patients (53.8%) not diagnosed with VRL, MDS detected pathogenic lymphoma mutations in 2 patients (28.6%). Discussion MDS detected pathogenic mutations in five out of six patients diagnosed with VRL, including in two patients with negative cytology, demonstrating its potential to improve diagnostic rates of VRL as an adjunctive test. No data are available.
目的 比较元基因组深度测序(MDS)与细胞学、流式细胞术和 PCR 基因重排对疑似玻璃体视网膜淋巴瘤(VRL)患者眼部样本的诊断效用。方法 2017年9月至2022年6月期间,疑似VRL患者在埃默里眼科中心接受了单眼或双眼眼部取样。用 MDS 和传统诊断方法对眼球样本进行评估。MDS在F.I. Proctor基金会的拉尔夫和索菲-海因茨实验室进行。从医疗记录中回顾性收集了相关的人口统计学和临床数据。患者根据临床评估和常规诊断测试被诊断为 VRL。结果 本研究共纳入 13 名疑似 VRL 患者,他们都接受了诊断性玻璃体切除术,其中 1 名患者还进行了视网膜下活检。六名患者(46.2%)被确诊为 VRL。在确诊为 VRL 的患者中,MDS 检测到 6 例患者中有 5 例(83.3%)存在致病基因突变,而细胞学检测为 VRL 阳性的患者有 4 例(66.7%),流式细胞术检测为 VRL 阳性的患者有 4 例(100.0%),PCR 检测为 VRL 阳性的患者有 4 例(100.0%)。在 6 名确诊为 VRL 的患者中,有 2 人的 MDS 检测出 MYD88 基因突变。在 7 名未确诊为 VRL 的患者(53.8%)中,MDS 检测到 2 名患者(28.6%)存在致病性淋巴瘤突变。讨论 在 6 名确诊为 VRL 的患者中,MDS 检测到了 5 名患者的致病性突变,其中包括 2 名细胞学检查呈阴性的患者,这表明 MDS 作为一种辅助检测方法具有提高 VRL 诊断率的潜力。暂无数据。
{"title":"Deep sequencing as a diagnostic tool in patients with suspected primary vitreoretinal lymphoma","authors":"Charlene Choo, Olivia Cote, Karina Bostwick, Matthew Regueiro, Jill Wells, Hans E Grossniklaus, John Gonzales, Steven Yeh, Armin Hinterwirth, Thuy Doan, Jessica G Shantha","doi":"10.1136/bjo-2023-324769","DOIUrl":"https://doi.org/10.1136/bjo-2023-324769","url":null,"abstract":"Purpose To compare the diagnostic utility of metagenomic deep sequencing (MDS) to cytology, flow cytometry and gene rearrangement by PCR in ocular samples of patients with suspected vitreoretinal lymphoma (VRL). Methods Patients with suspected VRL underwent ocular sampling of one or both eyes at the Emory Eye Center from September 2017 to June 2022. Ocular samples were evaluated with MDS and conventional diagnostics. MDS was performed at the Ralph and Sophie Heintz Laboratory at the F.I. Proctor Foundation. Relevant demographic and clinical data were retrospectively collected from medical records. Patients were diagnosed with VRL based on clinical assessment and conventional diagnostic testing. Results This study included 13 patients with suspected VRL who underwent diagnostic vitrectomy, including 1 patient who had an additional subretinal biopsy. Six patients (46.2%) were diagnosed with VRL. Among patients diagnosed with VRL, MDS detected pathogenic mutations in 5 out of 6 patients (83.3%) while cytology was positive for VRL in 4 out of 6 patients (66.7%), flow cytometry in 4 out of 4 patients (100.0%) and PCR in 4 out of 4 patients (100.0%). MDS detected mutations in MYD88 in 2 out of 6 patients diagnosed with VRL. In 7 patients (53.8%) not diagnosed with VRL, MDS detected pathogenic lymphoma mutations in 2 patients (28.6%). Discussion MDS detected pathogenic mutations in five out of six patients diagnosed with VRL, including in two patients with negative cytology, demonstrating its potential to improve diagnostic rates of VRL as an adjunctive test. No data are available.","PeriodicalId":9313,"journal":{"name":"British Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":4.1,"publicationDate":"2024-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141910362","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
British Journal of Ophthalmology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1